BTMD
biote Corp.·Healthcare
1.59
5.298%(+0.08)
Close PriceLast Updated: — ET
52W L: $1.2752W H: $4.75
BTMD NEWS
seekingalpha.com
Mar 11
biote Corp. (BTMD) Q4 2025 Earnings Call Transcript
biote Corp. (BTMD) Q4 2025 Earnings Call Transcript
zacks.com
Mar 11
biote Corp. (BTMD) Q4 Earnings and Revenues Top Estimates
biote Corp. (BTMD) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.1 per share a year ago.
businesswire.com
Mar 11
Biote Reports Fourth Quarter and Full Year 2025 Financial Results
IRVING, Texas--(BUSINESS WIRE)--Biote (NASDAQ: BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announced financial results for the fourth quarter and full year ended December 31, 2025. “Over the past twelve months, Biote has focused on our strategic priorities which are designed to drive sustainable profitable growth and create long-term value for stockholders,” said Bret Christensen, Biote's Chief.
businesswire.com
Feb 25
Biote Schedules Fourth Quarter and Full Year 2025 Financial Results Release and Conference Call
IRVING, Texas--(BUSINESS WIRE)--biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading innovator advancing the healthspan of patients' lives by providing hormone replacement therapy and healthy aging solutions, today announced the Company will provide fourth quarter and full year financial results on Wednesday, March 11, 2026, after the close of the market. A conference call to discuss the firm's results will be held at 5:00 p.m. ET. the same day. Conference Call Details The conferenc.
